Soc. Generale Knock-Out Vestas Wi.../ DE000SU3NGC3 /
| 23/05/2024 08:09:17 | Var.+0.19 | Denaro22:00:41 | Lettera22:00:41 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
|---|---|---|---|---|---|---|---|
| 2.81EUR | +7.25% | - Quantità in denaro: - |
- Quantità in lettera: - |
- | 170.7762 DKK | 31/12/2078 | Call |
GlobeNewswire
23:01
Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitab...
GlobeNewswire
23:01
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...
GlobeNewswire
23:01
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical...
GlobeNewswire
23:00
Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Co...
GlobeNewswire
23:00
Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term E...
GlobeNewswire
23:00
Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...
GlobeNewswire
23:00
Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting
GlobeNewswire
23:00
MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBIN...
GlobeNewswire
23:00
Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m...
GlobeNewswire
23:00
Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
23:00
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire
23:00
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...
GlobeNewswire
23:00
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology A...
GlobeNewswire
23:00
Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monothera...
GlobeNewswire
23:00
IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2...
GlobeNewswire
23:00
Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 ...
GlobeNewswire
23:00
Tizona Therapeutics Presents Phase 1b TTX-080 Clinical Data in Advanced Colorectal Cancer and Head a...
GlobeNewswire
23:00
Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at ...
GlobeNewswire
22:55
Park Aerospace Corp. Announces Date of Fiscal Year Earnings Release and Conference Call
